Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A XNAS: ASBP

Download real time

0.31 0.02 (6.90%)

98.04% Fall from 52W High

1.2M

XNAS Volume

XNAS 08 Jul, 2025 5:30 PM (EDT)

Insider Trading disclosures for Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A

The latest disclosure was made by Donald G. Fell in Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A where a trade of 9,500 Common Stock, par value $0.0001 done at an average price of $0.4 was reported to US exchanges on June 4, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Donald G. Fell	Director	Purchase of securities on an exchange or from another person at price $ 0.39 per share.	04 Jun 2025	9,500	9,500	-	0.4	3,705	Common Stock, par value $0.0001
Donald G. Fell	Director	Purchase of securities on an exchange or from another person at price $ 0.39 per share.	04 Jun 2025	10,500	20,000	-	0.4	4,095	Common Stock, par value $0.0001
Donald G. Fell	Director	Purchase of securities on an exchange or from another person at price $ 0.39 per share.	04 Jun 2025	9,500	9,500	-	0.4	3,705	Common Stock, par value $0.0001
Donald G. Fell	Director	Purchase of securities on an exchange or from another person at price $ 0.39 per share.	04 Jun 2025	10,500	20,000	-	0.4	4,095	Common Stock, par value $0.0001

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters